Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.
about
Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitis.Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.Anti-inflammatory therapies in sepsis and septic shock.Inhalation of beta 2 agonists impairs the clearance of nontypable Haemophilus influenzae from the murine respiratory tract.Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids.FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis.Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.Novel insights for systemic inflammation in sepsis and hemorrhage.The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi.Lack of effect of TNF antibodies on the cardiovascular sequelae of lipopolysaccharide infusion in conscious rats.Antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappaB abrogate fulminant septic shock induced by S. typhimurium in mice.Hepatoprotective effect of propagermanium on Corynebacterium parvum and lipopolysaccharide-induced liver injury in mice.Dimethyl Sulfoxide Attenuates Acute Lung Injury Induced by Hemorrhagic Shock/Resuscitation in Rats.The use of surrogate antibodies to evaluate the developmental and reproductive toxicity potential of an anti-TNFalpha PEGylated Fab' monoclonal antibody.
P2860
Q31893934-9F6DB4DF-8AAF-484B-9F6F-D686E293BD01Q33641577-5997FEFA-7E35-49C6-A95F-D2F48B7B21CCQ33904308-D9FDEF4C-CEC1-4C22-AD16-912DEE3B0C17Q34074976-5C710197-DE14-45FB-8ED0-6304E8D68090Q34590657-05B8F9C8-0FC6-4A5A-833A-3CD7C40F1CCDQ36364555-2415B0AA-F3BC-4E4E-BC03-0C9F300CF5B8Q36403918-7FAC7CD5-17F9-42C0-96C5-BEF9BCBE687CQ36548764-0F3962DB-2984-4E9C-BDC6-9BA59A6F6256Q37772404-8D4F0E8C-2A3E-44A8-B28B-3F71E5033848Q39512519-D7AB6691-5649-48A2-ABE5-E9CF096BD124Q42707914-92443C3D-A4DD-4F0C-A842-823AE814212CQ43736318-9C71C32A-D156-4A38-9B04-DD0972674B60Q44999481-752A9DDE-07DA-4239-9931-C2EEF7C0F44DQ51232011-70AB5D6C-21D6-4F8A-9A67-8CBD95B19E85Q51869946-CEC71950-B1FD-49D9-A74A-6970F2D8A4FE
P2860
Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Differential effect of isotype ...... in experimental septic shock.
@en
type
label
Differential effect of isotype ...... in experimental septic shock.
@en
prefLabel
Differential effect of isotype ...... in experimental septic shock.
@en
P2093
P2860
P356
P1476
Differential effect of isotype ...... in experimental septic shock.
@en
P2093
Chaplin LC
Palardy JE
Stephens S
Suitters AJ
P2860
P304
P356
10.1084/JEM.179.3.849
P407
P577
1994-03-01T00:00:00Z